Viveve Medical Inc
VIVE.OQ- Latest Trade
- trading higher0.72USD
- Change
- 0
- % Change
0.00%
- Day Range
- -- - --
- 52-Week Range
- 0.72 - 3.21
As of May 26 2022. Values delayed up to 15 minutes
- Previous Close
- 0.72
- Open
- 0.00
- Volume
- 0.00
- 3 Month Average Trading Volume
- 1.38
- Shares Out (Mil)
- 10.64
- Market Cap
- 7.88
- Forward P/E
- -0.28
- Dividend Yield
- -99,999.99
Key Statistics
1.5 mean rating - 2 analysts
- P/E Excl. Extra Items (TTM)
- -99,999.99
- Price To Sales (TTM)
- 1.19
- Price To Book (Quarterly)
- 0.78
- Price To Cash Flow (Per Share TTM)
- -99,999.99
- Total Debt/Total Equity (Quarterly)
- 52.04
- Long Term Debt/Equity (Quarterly)
- 0.00
- Return On Investment (TTM)
- -99.60
- Return On Equity (TTM)
- -74.78
2021 (millions USD)
About Viveve Medical Inc
Company Information
Viveve Medical, Inc. designs, develops, manufactures, and markets a platform medical technology, Cryogen-cooled Monopolar Radiofrequency (CMRF). The Company's CMRF technology is delivered through a radiofrequency (RF) generator, handpiece and treatment tip, that collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI), which is known as Viveve treatment. The Viveve System uses a method of delivering monopolar radiofrequency (RF) energy for treating tissue, such as Monopolar Radiofrequency Energy. The Viveve System also uses a cryogen surface cooling that enables volumetric heating of vaginal tissue. The Viveve System also uses a proprietary, controlled cryogen surface cooling that enables deep volumetric heating of vaginal tissue. The Company's subsidiary includes Viveve, Inc. and Viveve BV.
Address
345 Inverness Dr S Bldg B Ste 250ENGLEWOOD, CO
80112-5889
United States
Industry
Medical Equipment & Supplies
Executive Leadership
- Steven L. Basta
- Independent Chairman of the Board
- Scott C. Durbin
- Chief Executive Officer, Director
- Jim B. Robbins
- Senior Vice President - Finance and Administration
- Deborah Ann Jorn
- Director
- Arlene M. Morris
- Independent Director
- Sharon Collins Presnell
- Independent Director
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,852.20 | 0.25%Positive |
| Copper | 775.50 | 0.53%Positive |
| Brent Crude Oil | 117.12 | 0.24%Negative |
| CBOT Soybeans | 1,729.75 | 0.19%Positive |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,057.84 | 1.99%Positive |
| Euro STOXX 50 | 3,740.31 | -- |
| FTSE 100 | 7,564.92 | 0.56%Positive |
| Nikkei 225 | 26,781.68 | 0.66%Positive |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes